TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (TSM)

Executive Briefing

TSM remains a wonderful business, but not a clear bargain. The moat, balance sheet, earnings power, and AI bottleneck status argue strongly against AVOID. But at about 35x earnings, with heavy reinvestment needs and real geopolitical exposure, the stock does not clearly offer enough quality-scaled margin of safety for a Buffett-style long-term ADVOCATE call.

Best stance: WATCH. Refinement from prior thinking: this should be a constructive WATCH, meaning admiration plus readiness to act on either better price or clear proof intrinsic value is compounding faster than the market assumes. For investors who must have exposure, a small starter position / phased accumulation is more defensible than either full passivity or aggressive buying.

Key Arguments From Each Analyst

1) Risky Analyst — strongest pro-buy points

• TSM is a rare strategic bottleneck in advanced compute.
• Its moat is reinforced by process leadership, customer dependence, ecosystem lock-in, and advanced packaging.
• A premium multiple may be justified because this is not a normal cyclical semiconductor business.
• Heavy capex is not purely a burden; for TSM it can be moat-reinforcing.
• Technicals are supportive: above the 200 SMA, 50 SMA, and 10 EMA, suggesting ongoing institutional support.

What matters most: He is right that quality is exceptional and that old “cheap semiconductor” templates can understate the value of a dominant strategic infrastructure asset.

2) Safe Analyst — strongest caution points

• Around 35x earnings, the stock already reflects substantial optimism.
• A great business can still be a mediocre investment if bought too expensively.
• Future returns depend on successful execution in:
• AI/HPC growth,
• packaging monetization,
• overseas fab expansion,
• maintaining incremental returns despite political and cost pressures.
• Historical ROE does not prove future incremental returns on new capital remain equally strong.
• Geopolitical risk is real and deserves a higher required return, not dismissal because it is “well known.”

What matters most: He is right that moat is not margin of safety, and that valuation and geopolitical concentration still matter even for elite businesses.

3) Neutral Analyst — strongest synthesis points

• TSM deserves a premium, but the current premium still requires proof of delivery.
• Waiting forever for deep-value pricing can lead to perpetual non-ownership of elite franchises.
• But jumping from “premium business” to “buy now” is also too aggressive.
• The most sensible middle ground is partial participation / phased accumulation, not all-in and not total inactivity.

What matters most: This is the most practical framing: business quality says don’t reject it; valuation says don’t overcommit.

My Rationale

1) Business risk is low; investment risk is mostly price and geopolitics

Under Buffett-style risk analysis, the first question is whether the business faces likely permanent impairment. Based on the handoff, the answer is no:

• strong profitability,
• strong cash generation,
• no distress floor triggered,
• high ROE,
• strategic importance in advanced semis.

That means this is not a fundamentally fragile business. The major risks are:

• overpaying, and
• future returns on large incremental capital,
• with geopolitical concentration as a serious overlay.

So this is not a case where volatility itself is the main concern. The real issue is whether the current price already discounts too much success.

2) The bull wins on quality

The strongest evidence in favor of TSM:

• It is central to the AI and HPC stack.
• Its moat appears durable and based on capabilities, not just branding.
• Growth Analyst’s point is important: earnings power in 2–3 years may still be underestimated if compute intensity keeps rising.
• Value Analyst notes no distress and strong cash generation.
• Market Analyst confirms technical strength across major trend markers.

That combination is powerful. It argues strongly that TSM is too good to dismiss.

3) The bear wins on margin of safety

At the same time, this does not look like a classic value entry:

• P/E ~35x is not trivial for a capital-intensive foundry.
• Future economics must absorb:
• huge capex,
• global fab complexity,
• possible lower overseas returns,
• political influence on capacity location,
• concentrated geopolitical risk.

A wonderful business only needs a modest discount to intrinsic value, not a huge one. But I still want some quality-scaled margin of safety. Here, the evidence points more to fair to somewhat full than clearly discounted.

4) Prior lessons matter: do not let valuation alone blind you

Past reflection on TSM showed an important lesson: being too rigid on valuation caused missed upside in a high-quality secular leader. That lesson should change the tone here:

• Do not downgrade great businesses just because they are not statistically cheap.
• Respect trend and theme persistence in strategic bottlenecks.
• Do not overweight long-duration risks for a near-term setup.

However, the MU lesson adds the balancing correction:

• avoid using Buffett-style value screens too mechanically in semis,
• but also separate tactical participation from long-term full-throated advocacy.

That means the improved process is:

• Strategic stance: WATCH
• Tactical bias: constructive, selective accumulation on favorable setups rather than passive neglect

5) Why not ADVOCATE?

Because ADVOCATE should imply the stock offers a sufficiently attractive long-term expected return from today’s price. I do not think the handoff proves that yet.

To justify ADVOCATE here, I would want one of two things:

1. A better entry price creating a clearer quality-scaled discount; or
2. Fresh evidence that intrinsic value is compounding faster than current expectations, especially via:

• advanced packaging economics,
• resilient margins despite expansion,
• strong incremental returns on new fabs/capacity.

Without that, the case is admiration more than obvious undervaluation.

6) Why not AVOID?

Because AVOID would imply either:

• business quality breakdown,
• serious solvency/distress concerns,
• or a valuation so detached from reality that expected returns are plainly poor.

The handoff does not show that. Instead, it shows:

• elite franchise quality,
• strong profitability,
• no distress,
• secular demand tailwinds,
• positive technical structure.

That is far too strong for AVOID.

Refined Investor Plan

Starting from your original plan, I would keep the core stance as WATCH, but refine it based on the analysts and the lessons learned:

Updated plan

• Do not reject TSM.
• Do not chase aggressively at full size.
• Treat it as a constructive WATCH name.
• If portfolio policy allows, a small starter position / phased accumulation is reasonable.
• Add only on:

1. a more attractive price, or
2. confirming evidence that earnings power and returns on incremental capital are beating what today’s multiple already implies.

What to monitor over the next 1–4 quarters

1. Advanced-node and advanced-packaging demand

• Is packaging becoming a meaningful profit lever, not just a bottleneck headline?

1. Gross and operating margin resilience

• Can TSM expand and diversify geographically without structurally lower profitability?

1. Capex efficiency / incremental returns

• Are new fabs and overseas capacity earning acceptable returns?

1. Demand mix

• Is AI/HPC strength broad enough to offset softness elsewhere without overconcentration?

1. Management commentary

• Pricing power, utilization, customer commitments, packaging monetization, capital discipline.

1. Geopolitical developments

• Any worsening in cross-strait, export control, or politically mandated capex risk should increase required return.

Upgrade to ADVOCATE if:

• the stock offers a better entry point, or
• evidence shows intrinsic value is rising faster than market expectations through stronger margins, packaging economics, and high returns on incremental capital.

Move toward AVOID if:

• valuation re-rates sharply higher without earnings support,
• overseas fabs materially dilute returns,
• margin compression becomes structural,
• or geopolitical risk materially worsens.

Continuous Improvement From Past Mistakes

What I would do better than the earlier TSM review:

• Separate tactical and strategic judgment.
• Strategic long-term label can remain WATCH.
• Tactical posture can still be constructive.
• Do not let “not cheap” automatically mean “do nothing.”
• Respect secular leader behavior when trend and theme remain intact.
• But keep Buffett discipline by requiring some evidence of value support before moving to ADVOCATE.

This avoids both prior errors:

• the old mistake of being too valuation-rigid on elite compounders,
• and the opposite mistake of letting admiration erase entry discipline.

Final Stance

WATCH